APA (7th ed.) Citation

Scholz, E. P., Konrad, F. M., Weiss, D. L., Zitron, E., Seyler, C., Bloehs, R., . . . Karle, C. (2007). Anticholinergic antiparkinson drug orphenadrine inhibits HERG channels: Block attenuation by mutations of the pore residues Y652 or F656. Naunyn-Schmiedeberg's archives of pharmacology, 376(4), . https://doi.org/10.1007/s00210-007-0202-6

Chicago Style (17th ed.) Citation

Scholz, Eberhard P., et al. "Anticholinergic Antiparkinson Drug Orphenadrine Inhibits HERG Channels: Block Attenuation by Mutations of the Pore Residues Y652 or F656." Naunyn-Schmiedeberg's Archives of Pharmacology 376, no. 4 (2007). https://doi.org/10.1007/s00210-007-0202-6.

MLA (9th ed.) Citation

Scholz, Eberhard P., et al. "Anticholinergic Antiparkinson Drug Orphenadrine Inhibits HERG Channels: Block Attenuation by Mutations of the Pore Residues Y652 or F656." Naunyn-Schmiedeberg's Archives of Pharmacology, vol. 376, no. 4, 2007, https://doi.org/10.1007/s00210-007-0202-6.